Wellgistics Health, Inc.
$0.13
▼
-5.14%
2026-04-21 10:15:01
www.wellgisticshealth.com
NCM: WGRX
Explore Wellgistics Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$17.59 M
Current Price
$0.13
52W High / Low
$7.04 / $0.1
Stock P/E
—
Book Value
$-0.12
Dividend Yield
—
ROCE
-11952.35%
ROE
3545.19%
Face Value
—
EPS
$-1.43
Exp Qtr EPS
—
Sector
Healthcare
Industry
Pharmaceutical Retailers
Employees
—
Beta
—
Debt / Equity
-1.99
Current Ratio
0.1
Quick Ratio
0.04
Forward P/E
—
Price / Sales
0.62
Enterprise Value
$37.13 M
EV / EBITDA
-0.48
EV / Revenue
1.59
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
Cons
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cellyan Biotechnology Co., Ltd | $0.73 | — | $8.03 M | — | 3.09% | -13.38% | $2.76 / $0.37 | $0.47 |
| 2. | Ridgetech, Inc. | $2.21 | 0.16 | $2 M | — | -3.44% | -8.02% | $760.5 / $2.01 | $5.09 |
| 3. | Scienture Holdings, Inc. | $0.42 | — | $16.97 M | 12.89% | -19.95% | -55.65% | $2.6 / $0.24 | $1.73 |
| 4. | High Tide Inc. | $2.47 | — | $288.3 M | — | 6.2% | -39.72% | $5.59 / $2.85 | $0.72 |
| 5. | Cboe Global Markets, Inc. | NOT FOUND | — | — | 0.96% | 21.81% | 23.36% | $309.87 / $207.75 | $49.1 |
| 6. | Gilead Sciences, Inc. | $133.45 | 19.68 | $165.41 B | 2.41% | 24.79% | 40.66% | $157.29 / $93.37 | $18.29 |
| 7. | Walmart Inc. | $129.51 | 47.43 | $1,033.14 B | 0.79% | 16.83% | 21.85% | $134.69 / $91.34 | $12.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 1.67 M | 3.01 M | 7.79 M | 10.86 M | -16.05 M | — |
| Operating Profit | -12.8 M | -31.55 M | -5.5 M | -31.35 M | 0.53 M | — |
| Net Profit | -27.85 M | -34.32 M | -6.67 M | -32.43 M | 0.36 M | — |
| EPS in Rs | -0.23 | -0.29 | -0.06 | -0.27 | 0 | -0.04 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 23.34 M | 18.13 M | 0 M | 32.78 M |
| Operating Profit | -81.19 M | -6.15 M | -2.88 M | -3.42 M |
| Net Profit | -101.27 M | -6.86 M | -2.9 M | -2.74 M |
| EPS in Rs | -0.84 | -0.06 | -0.02 | -0.02 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 30.46 M | 57.33 M | 0.34 M | 0 M |
| Total Liabilities | 42.91 M | 50.6 M | 3.24 M | 0.01 M |
| Equity | -12.45 M | 6.73 M | -2.9 M | -0.01 M |
| Current Assets | 2.82 M | 15.17 M | 0.34 M | 0 M |
| Current Liabilities | 29.78 M | 38.05 M | 2.89 M | 0.01 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -10.86 M | -1.22 M | -0.35 M | 0 M |
| Investing CF | -0.88 M | 0.47 M | 0 M | — |
| Financing CF | 10.75 M | 1.78 M | 0.35 M | 0 M |
| Free CF | -11.74 M | -1.6 M | -0.35 M | 0 M |
| Capex | -0.88 M | -0.38 M | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 28.73% | — | -100% | — |
| Earnings Growth % | -1377.12% | -136.77% | -5.54% | — |
| Profit Margin % | -433.95% | -37.82% | — | -8.37% |
| Operating Margin % | -347.91% | -33.9% | — | -10.44% |
| Gross Margin % | -27.54% | 9.75% | — | 17.54% |
| EBITDA Margin % | -400.57% | -27.08% | — | -1.13% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.